1Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting : response variability, drug resistance, and the effect of pretreatment platelet reactivity[ J]. Circulation, 2003, 107 (23) :2908 -2913.
2Lau WC, Gurbel PA, Watkins PB, et al. Contribution of hepatic cytochromc P 450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J ]. Circulation, 2004, 109 ( 2 ) : 166 - 171.
3Softer D, Moussa I, Harjai K J, et al. Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention : do we need more aggressive dosing regimens in unstable angina? [ J ]. Catheter Cardiovasc Interv, 2003, 59(1) :21 -25.
4Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistanceis associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction [ J ]. Circulation, 2004, 109(25) :3171 -3175.
